Co-Authors
This is a "connection" page, showing publications co-authored by Mariska Leeflang and Clare Davenport.
Connection Strength
0.401
-
Letter to the Editor regarding Peto T; UK COVID-19 Lateral Flow Oversight Team: COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay. EClinicalMedicine. 2021 Aug; 38:101037.
Score: 0.060
-
Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev. 2021 03 24; 3:CD013705.
Score: 0.059
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19. Cochrane Database Syst Rev. 2021 02 23; 2:CD013665.
Score: 0.058
-
Routine laboratory testing to determine if a patient has COVID-19. Cochrane Database Syst Rev. 2020 11 19; 11:CD013787.
Score: 0.057
-
Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev. 2020 08 26; 8:CD013705.
Score: 0.056
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease. Cochrane Database Syst Rev. 2020 07 07; 7:CD013665.
Score: 0.056
-
Antibody tests for identification of current and past infection with SARS-CoV-2. Cochrane Database Syst Rev. 2020 06 25; 6:CD013652.
Score: 0.056